Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy

[1] Chang JC(2017)Opioid use and opioid use disorder in pregnancy. Committee opinion No. 711 Obstetrics & Gynecology 130 e81-e94

[2] Holland CL(2017)Perinatal illicit drug and marijuana use: An observational study examining prevalence, screening, and disclosure American Journal of Health Promotion 31 35-42

[3] Tarr JA(2005)The 4P's Plus© screen for substance use in pregnancy: Clinical application and outcomes Journal of Perinatology 25 368-374

[4] Rubio D(2007)Validation of the 4P's Plus© screen for substance use in pregnancy validation of the 4P's Plus Journal of Perinatology 27 744-748

[5] Rodriguez KL(2018)Comparison and validation of screening tools for substance use in pregnancy: A cross-sectional study conducted in Maryland prenatal clinics British Medical Journal Open 8 e020248-1047

[6] Kraemer KL(2019)Accuracy of three screening tools for prenatal substance use Obstetrics and Gynecology 133 952-367

[7] Chasnoff IJ(2019)Understanding barriers to timely identification of infants at risk of neonatal opiate withdrawal syndrome The Journal of Maternal-Fetal & Neonatal Medicine 34 1161-200

[8] McGourty RF(2008)Validation of the alcohol, smoking and substance involvement screening test (ASSIST) Addiction 103 1039-357

[9] Bailey GW(2005)The challenges of screening for substance use in pregnant women: Commentary on the 4P'S plus tool Journal of Perinatology 25 365-144

[10] Hutchins E(2010)Women's perspectives on screening for alcohol and drug use in prenatal care Women's Health Issues 20 193-undefined

[1] Chang JC(2017)Opioid use and opioid use disorder in pregnancy. Committee opinion No. 711 Obstetrics & Gynecology 130 e81-e94

[2] Holland CL(2017)Perinatal illicit drug and marijuana use: An observational study examining prevalence, screening, and disclosure American Journal of Health Promotion 31 35-42

[3] Tarr JA(2005)The 4P's Plus© screen for substance use in pregnancy: Clinical application and outcomes Journal of Perinatology 25 368-374

[4] Rubio D(2007)Validation of the 4P's Plus© screen for substance use in pregnancy validation of the 4P's Plus Journal of Perinatology 27 744-748

[5] Rodriguez KL(2018)Comparison and validation of screening tools for substance use in pregnancy: A cross-sectional study conducted in Maryland prenatal clinics British Medical Journal Open 8 e020248-1047

[6] Kraemer KL(2019)Accuracy of three screening tools for prenatal substance use Obstetrics and Gynecology 133 952-367

[7] Chasnoff IJ(2019)Understanding barriers to timely identification of infants at risk of neonatal opiate withdrawal syndrome The Journal of Maternal-Fetal & Neonatal Medicine 34 1161-200

[8] McGourty RF(2008)Validation of the alcohol, smoking and substance involvement screening test (ASSIST) Addiction 103 1039-357

[9] Bailey GW(2005)The challenges of screening for substance use in pregnant women: Commentary on the 4P'S plus tool Journal of Perinatology 25 365-144

[10] Hutchins E(2010)Women's perspectives on screening for alcohol and drug use in prenatal care Women's Health Issues 20 193-undefined